{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportversion": "2", "safetyreportid": "25599786", "primarysourcecountry": "US", "transmissiondateformat": "102", "transmissiondate": "20260415", "reporttype": "2", "serious": "1", "seriousnessdeath": "2", "seriousnesslifethreatening": "2", "seriousnesshospitalization": "1", "seriousnessdisabling": "2", "seriousnesscongenitalanomali": "2", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20250724", "receiptdateformat": "102", "receiptdate": "20260331", "fulfillexpeditecriteria": "1", "companynumb": "US-UCBSA-2025025141", "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "6", "senderorganization": "UCB" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "56", "patientonsetageunit": "801", "patientweight": "73.94", "reaction": [ { "reactionmeddraversionpt": "28.1", "reactionmeddrapt": "Vomiting", "reactionoutcome": "1" }, { "reactionmeddraversionpt": "28.1", "reactionmeddrapt": "Aortic valve incompetence", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "28.1", "reactionmeddrapt": "Diastolic dysfunction", "reactionoutcome": "3" }, { "reactionmeddraversionpt": "28.1", "reactionmeddrapt": "Left ventricular hypertrophy", "reactionoutcome": "3" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "FENFLURAMINE", "drugbatchnumb": "2050348", "drugauthorizationnumb": "212102", "drugstructuredosagenumb": "3", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "3 MILLILITER, 2X/DAY (BID)", "drugindication": "Lennox-Gastaut syndrome", "actiondrug": "1", "drugrecurreadministration": "3", "drugadditional": "1", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FENFLURAMINE", "drugauthorizationnumb": "212102", "drugseparatedosagenumb": "1", "drugdosagetext": "13.2MG PER DAY", "actiondrug": "1", "drugrecurreadministration": "3", "drugadditional": "1", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "1", "medicinalproduct": "FENFLURAMINE", "drugbatchnumb": "2121771", "drugauthorizationnumb": "212102", "drugstructuredosagenumb": "4.5", "drugstructuredosageunit": "012", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "4.5 MILLILITER, 2X/DAY (BID)", "actiondrug": "1", "drugrecurreadministration": "3", "drugadditional": "1", "activesubstance": { "activesubstancename": "FENFLURAMINE" }, "openfda": { "application_number": [ "NDA212102" ], "brand_name": [ "FINTEPLA" ], "generic_name": [ "FENFLURAMINE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "43376-322" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "FENFLURAMINE" ], "rxcui": [ "2381138", "2381144" ], "spl_id": [ "42264a61-0fc3-3a99-e063-6294a90a9595" ], "spl_set_id": [ "e88f360e-33ad-4cd6-b2de-5ef885857c5d" ], "package_ndc": [ "43376-322-30", "43376-322-36" ], "unii": [ "2DS058H2CF" ] } }, { "drugcharacterization": "2", "medicinalproduct": "BRIVIACT", "drugstructuredosagenumb": "100", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugdosagetext": "100 MILLIGRAM", "drugadministrationroute": "061", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "BRIVARACETAM" }, "openfda": { "application_number": [ "NDA205836", "NDA205838", "NDA205837" ], "brand_name": [ "BRIVIACT" ], "generic_name": [ "BRIVARACETAM" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "50474-370", "50474-470", "50474-570", "50474-670", "50474-770", "50474-870", "50474-970" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL", "INTRAVENOUS" ], "substance_name": [ "BRIVARACETAM" ], "rxcui": [ "1739749", "1739754", "1739761", "1739766", "1739768", "1739770", "1739772", "1739774", "1739776", "1739778", "1739780", "1739782", "1739785", "1739788" ], "spl_id": [ "597ca2bd-7caa-0d00-e063-6394a90a00c7" ], "spl_set_id": [ "3cf2f439-0e97-443e-8e33-25ecef616f6c" ], "package_ndc": [ "50474-370-66", "50474-470-66", "50474-470-09", "50474-470-14", "50474-570-66", "50474-570-09", "50474-570-14", "50474-670-66", "50474-770-66", "50474-770-09", "50474-770-14", "50474-870-15", "50474-970-63", "50474-970-75" ], "nui": [ "N0000192345" ], "pharm_class_moa": [ "Epoxide Hydrolase Inhibitors [MoA]" ], "unii": [ "U863JGG2IA" ] } }, { "drugcharacterization": "2", "medicinalproduct": "VITAMIN D3", "drugstructuredosagenumb": "25", "drugstructuredosageunit": "004", "drugseparatedosagenumb": "1", "drugdosagetext": "25 MICROGRAM", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "CHOLECALCIFEROL" }, "openfda": { "application_number": [ "ANDA090455" ], "brand_name": [ "VITAMIN D" ], "generic_name": [ "ERGOCALCIFEROL" ], "manufacturer_name": [ "Strides Pharma Science Limited" ], "product_ndc": [ "64380-737" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ERGOCALCIFEROL" ], "rxcui": [ "1367410" ], "spl_id": [ "1cc589f7-cd6d-40a6-8fce-c965e8945eae" ], "spl_set_id": [ "2c4c0a36-12cf-444d-9d57-de983eef4d36" ], "package_ndc": [ "64380-737-06", "64380-737-25" ], "nui": [ "M0007651", "N0000175909" ], "pharm_class_cs": [ "Ergocalciferols [CS]" ], "pharm_class_epc": [ "Provitamin D2 Compound [EPC]" ], "unii": [ "VS041H42XC" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CLOBAZAM", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "10 MILLIGRAM, ONCE DAILY (QD)", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "CLOBAZAM" }, "openfda": { "application_number": [ "NDA210833", "ANDA213404", "ANDA211711", "ANDA210978", "ANDA213110", "ANDA214404", "ANDA208819", "ANDA209795", "ANDA209796", "ANDA210545", "ANDA209718", "ANDA210039", "ANDA212714", "NDA203993", "NDA202067", "ANDA213039", "ANDA209687" ], "brand_name": [ "SYMPAZAN", "CLOBAZAM", "ONFI" ], "generic_name": [ "CLOBAZAM" ], "manufacturer_name": [ "Aquestive Therapeutics", "Novadoz Pharmaceuticals LLC", "Micro Labs Limited", "Sun Pharmaceutical Industries, Inc.", "Chartwell RX, LLC", "Aurobindo Pharma Limited", "Bionpharma Inc.", "Camber Pharmaceuticals, Inc.", "NorthStar RxLLC", "Lupin Pharmaceuticals, Inc.", "Amneal Pharmaceuticals NY LLC", "Ascend Laboratories, LLC", "Lundbeck Pharmaceuticals LLC", "Upsher-Smith Laboratories, LLC" ], "product_ndc": [ "10094-205", "10094-210", "10094-220", "72205-047", "72205-048", "42571-315", "42571-316", "51672-4227", "62135-527", "59651-401", "69452-116", "31722-639", "31722-640", "16714-087", "16714-887", "16714-888", "68180-157", "68180-158", "69238-1305", "69238-1306", "69238-1535", "67877-664", "67877-665", "67877-666", "67386-313", "67386-314", "67386-315", "31722-641", "67877-658", "0832-0580", "0832-0581" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CLOBAZAM" ], "rxcui": [ "2058253", "2058254", "2058255", "2102713", "2102715", "2102717", "199450", "246172", "1366192", "427538", "1191056", "1191058", "1366196" ], "spl_id": [ "4a004ed9-140a-4054-843c-4e31d42667ec", "3c8a899d-7c67-43d5-9428-0c0d0f9583de", "50d350cb-6640-b3c2-e063-6394a90a397b", "569900df-15bd-52e4-e063-6394a90aaa0b", "181bd7dd-a848-7bc7-e063-6294a90a482c", "df4d6b4b-9864-4c24-92e1-4a72c2863b5f", "27d7f38a-1122-d6bb-e063-6394a90a5cd8", "22eea187-7659-07de-e063-6394a90a5dca", "f649cb16-8cb4-5292-e053-2995a90a04fc", "223818f1-9350-07e9-e063-6294a90ab33a", "ce8d2e9b-0cf3-4206-9523-6f0df27953b8", "182c75a8-797a-457e-915b-c3297e71b43b", "cf085b2b-564e-4109-90e7-1d27fcbca810", "f9dc8ac4-86be-49ab-9c2c-c60658f49d8f", "68dbe31c-2dbe-49ad-8b2e-2cf1b8521167", "556132d3-7f61-e679-e063-6394a90a4528", "1555689f-8f9a-4042-8a94-911e90904dd0", "1e02d082-c325-6bd1-e063-6294a90a14ac" ], "spl_set_id": [ "5e3d8fcb-aa7d-4822-88fc-4f06264c3242", "cf5bb37f-5386-47d3-8cec-d48253d359f6", "721dde68-db83-4dad-8649-8046cb455372", "fd1e63bf-496c-427c-83b7-6acabc00a5e5", "17c3b9db-9e25-4a17-ac45-bcd17ea0360c", "1b5749a1-1c6d-4243-a833-4bfd84f9d5a9", "4b92ac57-25aa-4c00-b062-dee3944b271b", "cf31b8d1-0d19-4529-99b6-1f7366064a3c", "574a3f91-d73e-46bc-b4a1-2388439521fb", "6f94e10e-ee4e-44e1-9c84-16c5d8c9b594", "d9e03a2a-3fea-4c98-ab71-415e6ebda3e0", "6783eaa8-e236-4957-aaa9-b42bf8e709a7", "a526ad73-d3c1-40b7-8e71-426b01cdea27", "a77ffbdd-4e3e-4ec4-b0fa-b51ee610df0f", "de03bd69-2dca-459c-93b4-541fd3e9571c", "c9b51794-3cfa-4a34-b5bb-d523b5798c17", "07e0ae51-cc71-427f-83cb-311b7fcc5993", "6da2c381-057b-456a-b57b-464f8b383371" ], "package_ndc": [ "10094-205-01", "10094-205-60", "10094-210-01", "10094-210-60", "10094-220-01", "10094-220-60", "72205-047-91", "72205-048-91", "42571-315-30", "42571-315-90", "42571-315-05", "42571-315-32", "42571-315-11", "42571-315-20", "42571-315-91", "42571-315-01", "42571-316-30", "42571-316-90", "42571-316-32", "42571-316-11", "42571-316-20", "42571-316-91", "42571-316-01", "51672-4227-8", "62135-527-41", "59651-401-12", "69452-116-45", "31722-639-01", "31722-639-31", "31722-640-01", "31722-640-31", "16714-087-01", "16714-887-01", "16714-888-01", "68180-157-06", "68180-157-07", "68180-157-09", "68180-157-01", "68180-157-02", "68180-158-06", "68180-158-07", "68180-158-09", "68180-158-01", "68180-158-02", "69238-1305-1", "69238-1306-1", "69238-1535-2", "67877-665-01", "67877-665-05", "67877-665-33", "67877-666-01", "67877-666-05", "67877-666-33", "67877-664-01", "67877-664-05", "67877-664-33", "67386-314-01", "67386-315-01", "67386-313-21", "31722-641-12", "67877-658-61", "0832-0580-11", "0832-0581-11" ], "nui": [ "N0000175694", "M0002356", "N0000182137", "N0000185506" ], "pharm_class_epc": [ "Benzodiazepine [EPC]" ], "pharm_class_cs": [ "Benzodiazepines [CS]" ], "pharm_class_moa": [ "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]" ], "unii": [ "2MRO291B4U" ] } }, { "drugcharacterization": "2", "medicinalproduct": "EPIDIOLEX", "drugseparatedosagenumb": "1", "drugdosagetext": "UNK", "drugadministrationroute": "061", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "CANNABIDIOL" }, "openfda": { "application_number": [ "NDA210365" ], "brand_name": [ "EPIDIOLEX" ], "generic_name": [ "CANNABIDIOL" ], "manufacturer_name": [ "Jazz Pharmaceuticals, Inc." ], "product_ndc": [ "70127-100" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CANNABIDIOL" ], "rxcui": [ "2058900", "2058906" ], "spl_id": [ "1eb7ac65-8df5-4a4a-9156-802cfaa92b06" ], "spl_set_id": [ "8bf27097-4870-43fb-94f0-f3d0871d1eec" ], "package_ndc": [ "70127-100-01", "70127-100-10", "70127-100-06", "70127-100-60" ], "nui": [ "M0003267", "N0000187062", "N0000185504", "N0000182140", "N0000191278", "N0000191273", "N0000182138", "N0000182139", "N0000187064" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "pharm_class_moa": [ "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]" ], "unii": [ "19GBJ60SN5" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CYANOCOBALAMIN\\FOLIC ACID\\PYRIDOXINE HYDROCHLORIDE", "drugseparatedosagenumb": "1", "drugdosagetext": "2.5--25-1 MG", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "CYANOCOBALAMIN\\FOLIC ACID\\PYRIDOXINE HYDROCHLORIDE" } }, { "drugcharacterization": "2", "medicinalproduct": "VIMPAT", "drugstructuredosagenumb": "100", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugdosagetext": "100 MILLIGRAM", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "LACOSAMIDE" }, "openfda": { "application_number": [ "NDA022254", "NDA022253", "NDA022255" ], "brand_name": [ "VIMPAT" ], "generic_name": [ "LACOSAMIDE" ], "manufacturer_name": [ "UCB, Inc." ], "product_ndc": [ "0131-1810", "0131-2477", "0131-2478", "0131-2479", "0131-2480", "0131-5410" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAVENOUS", "ORAL" ], "substance_name": [ "LACOSAMIDE" ], "rxcui": [ "809974", "809984", "809987", "809990", "809992", "809994", "809996", "809998", "810000", "810002", "993856", "995156" ], "spl_id": [ "51a12988-3e4b-c52b-e063-6394a90a7415" ], "spl_set_id": [ "9e79b42c-38a3-4b2c-a196-a5a1948250e2" ], "package_ndc": [ "0131-2477-35", "0131-2477-60", "0131-2477-99", "0131-2478-35", "0131-2478-60", "0131-2478-99", "0131-2479-35", "0131-2479-60", "0131-2479-99", "0131-2480-35", "0131-2480-60", "0131-2480-99", "0131-1810-67", "0131-5410-70", "0131-5410-71", "0131-5410-72" ], "nui": [ "N0000008486" ], "pharm_class_pe": [ "Decreased Central Nervous System Disorganized Electrical Activity [PE]" ], "unii": [ "563KS2PQY5" ] } }, { "drugcharacterization": "2", "medicinalproduct": "GLUCOPHAGE", "drugstructuredosagenumb": "500", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugdosagetext": "500 MILLIGRAM", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "METFORMIN HYDROCHLORIDE" } }, { "drugcharacterization": "2", "medicinalproduct": "SINGULAIR", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "10 MILLIGRAM, ONCE DAILY (QD)", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "MONTELUKAST SODIUM" }, "openfda": { "application_number": [ "NDA020830", "NDA021409", "NDA020829" ], "brand_name": [ "SINGULAIR" ], "generic_name": [ "MONTELUKAST SODIUM" ], "manufacturer_name": [ "Organon LLC" ], "product_ndc": [ "78206-170", "78206-171", "78206-173", "78206-172" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "MONTELUKAST SODIUM" ], "rxcui": [ "153892", "153893", "200224", "242438", "261367", "311759", "351246", "404406" ], "spl_id": [ "57a12189-3bb3-4a5d-b5fe-fc57db87c134" ], "spl_set_id": [ "482dcc92-b47f-4ea6-854a-f5ac2aea7842" ], "package_ndc": [ "78206-171-01", "78206-170-01", "78206-173-01", "78206-172-01", "78206-172-02" ], "unii": [ "U1O3J18SFL" ] } }, { "drugcharacterization": "2", "medicinalproduct": "PEG 3350", "drugseparatedosagenumb": "1", "drugdosagetext": "MIX 1 PACKET IN 8 OUNCES OF LIQUID AND DRINK BY MOUTH EVERY DAY (HOLD FOR LOOSE STOOL)", "drugadministrationroute": "061", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "POLYETHYLENE GLYCOL 3350" } }, { "drugcharacterization": "2", "medicinalproduct": "VASCEPA", "drugstructuredosagenumb": "2", "drugstructuredosageunit": "002", "drugseparatedosagenumb": "1", "drugdosagetext": "2 GRAM", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "ICOSAPENT ETHYL" }, "openfda": { "application_number": [ "NDA202057" ], "brand_name": [ "VASCEPA" ], "generic_name": [ "ICOSAPENT ETHYL" ], "manufacturer_name": [ "Amarin Pharma Inc." ], "product_ndc": [ "52937-001", "52937-101", "52937-003", "52937-005" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "ICOSAPENT ETHYL" ], "rxcui": [ "1304979", "1304985", "1811180", "1811182" ], "spl_id": [ "86b35fe3-d1cf-478e-849b-2ea0c87bda33" ], "spl_set_id": [ "9c1a2828-1583-4414-ab22-a60480e8e508" ], "package_ndc": [ "52937-001-04", "52937-001-20", "52937-001-21", "52937-101-08", "52937-003-40", "52937-003-16", "52937-005-20" ], "unii": [ "6GC8A4PAYH" ] } }, { "drugcharacterization": "2", "medicinalproduct": "XCOPRI", "drugstructuredosagenumb": "150", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "150 MILLIGRAM, ONCE DAILY (QD)", "drugindication": "Product used for unknown indication", "activesubstance": { "activesubstancename": "CENOBAMATE" }, "openfda": { "application_number": [ "NDA212839" ], "brand_name": [ "XCOPRI", "XCOPRI MAINTENANCE PACK", "XCOPRI TITRATION PACK" ], "generic_name": [ "CENOBAMATE" ], "manufacturer_name": [ "SK Life Science, Inc." ], "product_ndc": [ "71699-025", "71699-201", "71699-050", "71699-202", "71699-100", "71699-150", "71699-203", "71699-103", "71699-200", "71699-104", "71699-204" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CENOBAMATE" ], "rxcui": [ "2265695", "2265701", "2283503", "2283505", "2283507", "2283509", "2283511", "2283513", "2283517", "2283518", "2283520", "2283522", "2283523", "2283525", "2283527", "2283535", "2283536", "2283538", "2283539", "2283540", "2540431", "2540432", "2683673", "2683674" ], "spl_id": [ "a4bdf970-9ffa-11f1-b55a-0800200c9a66" ], "spl_set_id": [ "565c2126-57ae-4e29-b443-723bbe7e2072" ], "package_ndc": [ "71699-201-28", "71699-050-30", "71699-050-99", "71699-202-28", "71699-025-30", "71699-100-30", "71699-150-30", "71699-203-28", "71699-103-56", "71699-200-30", "71699-104-56", "71699-204-14" ], "nui": [ "N0000181004", "N0000193997", "N0000182139", "N0000182140", "N0000190114", "N0000187064", "N0000187063", "N0000185506" ], "pharm_class_moa": [ "Sodium Channel Antagonists [MoA]", "GABA A Receptor Positive Modulators [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]" ], "unii": [ "P85X70RZWS" ] } } ] } } ] }